Weekly Clinical Updates

As infectious diseases such as SARS, Monkeypox, Polio, HIV, and Ebola travel the globe and garner media attention, Parasites Without Borders staff are curating resources in a timely, ongoing basis. We believe the information posted here is worthy of further examination by the science and medical communities. Our primary goal remains to bring the latest medical and biological information to the forefront for researchers and practicing physicians.

FIMRC Fundraiser x Parasites Without Borders Kicks Off This Spring

Throughout May, June, and July, donations made to Parasites Without Borders (PWB) will be matched by the organization and donated to Foundation for International Medical Relief of Children (FIMRC), for a total gift of up to $10,000. Founded in 2002 by Dr. Vikram D. Bakhru, FIMRC is a U.S.-based nonprofit organization that works to improve access to care through innovative, self-sustaining health programs. FIMRC works alongside communities to improve health from the ground up — including building necessary infrastructure, such as constructing or updating buildings; ensuring communities have access to a healthcare professional; and educating on preventive health.
Learn more at fimrc.org

SHOW YOUR SUPPORT - DONATE NOW

MicrobeTV Podcast

MicrobeTV is an independent podcast network for people who are interested in the life sciences. Our shows are about viruses, bacteria, parasites, evolution, immunology, and neuroscience.

MicrobeTV Podcast

March 7, 2024

Interim Effectiveness of Updated 2023–2024 COVID-19 Vaccines Against COVID-19 | Combined Protection of Vaccination and Nirmatrelvir-ritonavir in Adults | Ivermectin for COVID-19 in Adults in the Community (PRINCIPLE): An Open, Randomised, Controlled, Adaptive Platform | Cognition and Memory after COVID-19 in a Large Community Sample | Prospective Memory Assessment Before and After Covid-19 | What is the Impact of Long-term COVID-19 on Workers

View Updates

February 29, 2024

Effectiveness of Nirmatrelvir-ritonavir on Severe Outcomes of COVID-19 in the Era of Vaccination | Randomized Controlled Trial of Molnupiravir SARS-CoV-2 Viral and Antibody Response | Spontaneous, Persistent, T cell–dependent IFN-γ Release in Patients | Blood–brain Barrier Disruption and Sustained Systemic Inflammation in Individuals | Prevalence of Persistent SARS-CoV-2 in a Large Community Surveillance Study | Long Term Outcomes of Hyperbaric Oxygen Therapy in Post Covid Condition

View Updates

February 22, 2024

Self-administered versus Clinician-performed BinaxNOW COVID Rapid Test: A Comparison of Accuracy | The Impact of COVID-19 Vaccination Prior to SARS-CoV-2 Infection on Prevalence of Long COVID among a Population-based Probability Sample of Michiganders, 2020-2022 | Estimates of Incidence and Predictors of Fatiguing Illness after SARS-CoV-2 Infection | Long-term risks of Respiratory Diseases in Patients Infected with SARS-CoV-2

View Updates

Research findings on RSV and flu vaccines

February 15, 2024

Early Estimates of Nirsevimab Immunoprophylaxis Effectiveness against Hospital Admission | Redirecting Antibody Responses from Egg-adapted Epitopes Following Repeat Vaccination | Risk of Cardiovascular Events after Influenza | Risk of Death Following Chikungunya Virus Disease | Comparative Effectiveness of Alternative Intervals Between First and Second Doses | Early Mortality After the First Dose of Coronavirus Disease

View Updates

Mother with her newborn baby at the hospital in front of a window

February 8, 2024

Estimating the Heritability of SARS-CoV-2 Susceptibility and COVID-19 Severity | Neonatal Outcomes After COVID-19 Vaccination in Pregnancy | Contralateral Second Dose Improves Antibody Responses to a Two-dose mRNA Vaccination Regimen | Substantial Health and Economic Burden of COVID-19 During the Year After Acute Illness Among US Adults Not at High Risk of Severe COVID-19

View Updates

Mature man holding his shirt sleeve up while wearing mask as doctor administers vaccine in upper arm

January 31, 2024

Efficacy and safety of respiratory syncytial virus (RSV) prefusion F protein vaccine (RSVPreF3 OA) in older adults over 2 RSV seasons | Effectiveness of High-dose vs. Standard-dose Quadrivalent Influenza Vaccine against Recurrent Hospitalizations and Mortality in Relation to Influenza Circulation: A Post-hoc Analysis of the DANFLU-1 Randomized Clinical Trial

View Updates

« Anterior
1
…
18
19
20
21
22
…
53
Siguiente »

Situation Dashboards

World Health Organization (WHO)

Novel Coronavirus (COVID-19) Situation from World Health Organization (WHO)

View Dashboard

Johns Hopkins University (JHU)

Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at JHU

View Dashboard

COVID-19 in US and Canada

1Point3Acres Real-Time Coronavirus (COVID-19) Updates in US and Canada with Credible Sources

View Dashboard

Genomic Epidemiology COVID-19

Genomic Epidemiology of (COVID-19) Maintained by the Nextstrain team, enabled by data from GISAID.

View Dashboard

Weekly Clinical Updates

MicrobeTV Podcast

March 7, 2024

February 29, 2024

February 22, 2024

February 15, 2024

February 8, 2024

January 31, 2024

Situation Dashboards

World Health Organization (WHO)

Johns Hopkins University (JHU)

COVID-19 in US and Canada

Genomic Epidemiology COVID-19

Sources for COVID-19 Information

World Health Organization (WHO)

Centers for Disease Control, US

International Society for Infectious Diseases

This Week in Virology (TWIV)

Donate to Parasites Without Borders Today!